Miss Ines Semendric

Research Officer

Office of Health

College of Health


Ines holds a Bachelor of Health and Medical Science (Neuroscience) with Honours (Physiology) and is undertaking her Doctor of Philosophy in Medicine. She is a member of the Cognition, Ageing and Neurodegenerative Disease laboratory (CANDL) and Animal Welfare, Cognitive and Affective Neuroscience (AWCAN) laboratory.

Her research focuses on Cancer-Related Cognitive Impairment in children who are survivors of childhood cancer. She is particularly interested in characterising this condition further in children, and seeks to maintain/improve cognition through a novel cognitive gaming suite funded by the Channel 7 Children's Research Foundation Annual 2023 grant.

Ines is also a Research Officer at HESRI (Health Evidence Synthesis Recommendations and Impact) in the School of Public Health with a focus on the development of Australia's Motor Neurone Disease (MND) Guidelines (https://mndguideline.org.au/).

Date Type Title Institution Name Country Amount
2024 Award Outstanding Oral Presentation Award Australasian Cognitive Neuroscience Society Australia -
2022 Award Lions Medical Research Foundation Prize The University of Adelaide Australia -

Date Institution name Country Title
2021 University of Adelaide Australia PhD in Medicine,
2019 - 2020 University of Adelaide Australia Bachelor of Health and Medical Sciences (Honours)
2016 - 2018 University of Adelaide Australia Bachelor of Health and Medical Sciences

Year Citation
2026 Stern, C., Pollock, D., Barker, T., Holland, G. M., Hasanoff, S., Shrestha, N., . . . Munn, Z. (2026). Protocol for the Development of The Australian Motor Neurone Disease (MND) Guideline. Clinical and Public Health Guidelines, 3(1).
DOI
2025 Haller, O. J., Semendric, I., Collins-Praino, L. E., Whittaker, A. L., & George, R. P. (2025). Changes in cognition and astrocytic reactivity in a female rodent model of chemotherapy-induced cognitive impairment are variable both acutely and chronically. Behavioural Brain Research, 480, 115391-1-115391-15.
DOI Scopus1 WoS1 Europe PMC1
2025 Whittaker, A. L., & Semendric, I. (2025). Reassessing cognitive impairment prevalence in 5-FU chemotherapy: A critical methodological perspective. Cancer Research, Statistics, and Treatment, 8(1), 83-84.
DOI
2025 Stern, C., Semendric, I., Shrestha, N., Beasley-Hall, J., Hasanoff, S., Barker, T., . . . Munn, Z. (2025). Guidelines addressing Motor Neurone Disease (MND): a scoping review. Neurodegenerative Disease Management, 16 pages.
DOI
2025 Semendric, I., Barker, T. H., Haller, O. J., Pollock, D., Collins-Praino, L. E., & Whittaker, A. (2025). Prevalence of cancer-related cognitive impairment in pediatric patients and survivors: a systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews, 176, 106283-1-106283-33.
DOI WoS1 Europe PMC1
2024 Abdalla-Aslan, R., Bonomo, P., Keefe, D., Blijlevens, N., Cao, K., Cheung, Y. T., . . . Nagano, C. (2024). Guidance on mucositis assessment from the MASCC Mucositis Study Group and ISOO: an international Delphi study. eClinicalMedicine, 73(102675), 102675-1-102675-12.
DOI Scopus8 WoS9 Europe PMC7
2023 Haller, O. J., Semendric, I., George, R. P., Collins-Praino, L. E., & Whittaker, A. L. (2023). The effectiveness of anti-inflammatory agents in reducing chemotherapy-induced cognitive impairment in preclinical models – a systematic review. Neuroscience & Biobehavioral Reviews, 148, 105120-1-105120-37.
DOI Scopus8 WoS6 Europe PMC5
2023 Domínguez-Oliva, A., Mota-Rojas, D., Semendric, I., & Whittaker, A. (2023). The impact of vegan diets on indicators of health in dogs and cats: a systematic review. Veterinary Sciences, 10(1), 1-25.
DOI Scopus20 WoS15 Europe PMC8
2023 Semendric, I., Pollock, D., Haller, O., George, R., Collins-Praino, L., & Whittaker, A. (2023). "Chemobrain" in childhood cancer survivors - the impact on social, academic, and daily living skills: a qualitative systematic review. Supportive Care in Cancer, 31(9), 532-1-532-15.
DOI Scopus11 WoS9 Europe PMC5
2022 Semendric, I., Pollock, D., Haller, O., George, R., Collins-Praino, L., & Whittaker, A. (2022). ‘‘Chemobrain’’ in childhood cancer survivors - the impact on social, academic, and daily living skills: a qualitative systematic review protocol. JBI Evidence Synthesis, 20(1), 222-228.
DOI Scopus3 WoS3 Europe PMC3
2021 George, R., Semendric, I., Hutchinson, M., & Whittaker, A. (2021). Neuroimmune reactivity marker expression in rodent models of chemotherapy-induced cognitive impairment: a systematic scoping review. Brain, Behavior, and Immunity, 94, 392-409.
DOI Scopus16 WoS16 Europe PMC16
2021 George, R., Semendric, I., Bowley-Schubert, E., Chivonivoni, C., Warrender, A., & Whittaker, A. (2021). Reporting in rodent models of 'chemobrain': a systematic review assessing compliance with the ARRIVE guidelines. Supportive Care in Cancer, 29(11), 7073-7084.
DOI Scopus8 WoS8 Europe PMC9

Year Citation
2021 Haller, O., Whittaker, A., George, R., Semendric, I., & Collins-Praino, L. (2021). Investigating the effects of anti-inflammatory agents in pre-clinical models of chemotherapy-induced cognitive impairment – a systematic review protocol. PROSPERO- registration no: CRD42021240789.
2021 Semendric, I., Haller, O., George, R., Pollock, D., Whittaker, A., & Collins-Praino, L. (2021). Experience of the impact of chemobrain in childhood cancer survivors: a qualitative systematic review protocol. PROSPERO 2021 CRD42021240573. PROSPERO.

Year Citation
2025 Semendric, I., Barker, T., Haller, O., Pollock, D., Collins-Praino, L., & Whittaker, A. (2025). Prevalence of cancer-related cognitive impairment in pediatric patients and survivors of non-CNS cancers: A systematic review and meta-analysis.
DOI
2024 Haller, O., Semendric, I., Collins-Praino, L., Whittaker, A., & George, R. (2024). Changes in cognition and neuroinflammation in a rodent model of chemotherapy-induced cognitive impairment are variable both acutely and chronically.
DOI
Date Project Investigators Funding Body Amount
01 March 2021 to 01 March 2023 Research Training Program PhD Scholarship Semendric I The University of Adelaide $32,000
01 March 2023 to 28 Feb 2025 "Can cognitive function be improved in childhood cancer survivors with the use of a custom cognitive gaming suite?" Collins-Praino L; Whittaker A; Hobbs D; Pope K; Semendric I; O'Loughlin R; Haller O; George R Channel 7 Children's Research Foundation Annual Grant 2023 $100,000
Subject Role Year
HLTH SC 1001 - Essentials of Neuroscience Tutor 2021
ANIML SC 3100RW - Laboratory Animal Science III Lab Demonstrator 2021
VET TECH 1030RW - Evidence-based Veterinary Technology I Assessment Marker 2022
MEDIC ST 1501 - Foundations of Medicine Workshop Demonstrator 2022
ANAT SC 2006 - Foundations of Human Neuroanatomy Lab Demonstrator 2022
VET TECH 1030RW - Evidence-based Veterinary Technology I Assessment Marker 2023
HLTH SC 1002 - Create. Communicate. Connect. Tutor and Assessment Marker

2024

 

MEDIC ST 1501 - Foundations of Medicine Workshop Demonstrator 2024
VET TECH 1030RW - Evidence-based Veterinary Technology I Assessment Marker 2024

Date Role Research Topic Location Program Supervision Type Student Load Student Name
2022 - 2022 Other Prevalence of chemotherapy-induced cognitive impairment in childhood cancer survivors The University of Adelaide Bachelor of Health and Medical Sciences Third Year Research Placement Other Full Time Clancy Bright, Rowan Douglass, Ananno Arunima

Date Role Membership Country
2025 - ongoing Member GRADE Working Group Australia
2025 - ongoing Member Guidelines International Network (GIN) Australia
2025 - ongoing Member Evidence Synthesis Taxonomy (ESTI) Advisory Board Australia
2024 - ongoing Member Healthy Development Adelaide Australia
2023 - ongoing Member Australasian Cognitive Neuroscience Society Australia
2023 - 2024 Member Australasian Society for Social and Affective Neuroscience Australia
2022 - 2023 Member Australasian Neuroscience Society Australia
2020 - 2022 Member Multinational Association of Supportive Care in Cancer (MASCC) Australia

Date Topic Presented at Institution Country
2025 - 2025 Beyond Cancer: 'Chemobrain' and Support Challenges for Young Adult Childhood Cancer Survivors Cancer Council SA Social and Behavioural Cancer Research Symposium Cancer Council SA Australia
2024 - 2024 Beyond Cancer: 'Chemobrain' and Support Challenges for Young Adult Childhood Cancer Survivors Australasian Cognitive Neuroscience Society The University of Newcastle Australia
2024 - 2024 Beyond Cancer: 'Chemobrain' and Support Challenges for Young Adult Childhood Cancer Survivors Healthy Development Adelaide 20th Anniversary Research Symposium The University of Adelaide Australia
2024 - 2024 Prevalence of cancer-related cognitive impairment in paediatric patients and survivors of non-CNS cancers: a systematic review and meta-analysis Florey Postgraduate Research Conference The University of Adelaide Australia
2023 - ongoing In Their Own Words: A Qualitative Systematic Review of ‘Chemobrain’ in Childhood Cancer Survivors Florey Postgraduate Conference The University of Adelaide -
2023 - 2023 'Chemobrain' in survivors of childhood cancer - the impact on social, academic, and daily living skills: A qualitative systematic review MASCC/JASCC/ISOO 2023 Annual Meeting Multinational Association of Supportive Care in Cancer (MASCC) Japan
2023 - 2023 ‘Chemobrain' in childhood cancer survivors – social, academic, and daily living: aqualitative systematic review The Australasian Society for Social and Affective Neuroscience Conference AS4SAN -
2023 - 2023 ‘Chemobrain' in childhood cancer survivors – social, academic, and daily living: aqualitative systematic review The Australasian Society for Social and Affective Neuroscience Conference AS4SAN -
2022 - ongoing Acute, sub-acute, and chronic effects of Methotrexate and 5-Fluorouracil in a Rodent Model of Chemotherapy-Induced Cognitive Impairment Australasian Neuroscience Society Conference Australasian Neuroscience Society -
2022 - ongoing Neuroimmune reactivity marker expression in rodent models of chemotherapy- induced cognitive impairment: A systematic scoping review Florey Postgraduate Research Conference The University of Adelaide -
2021 - ongoing Chemobrain: Assessing the effects of chemotherapy drugs, MTX and 5-FU treatment, at multiple time-points Florey Undergraduate Conference The University of Adelaide -
2021 - ongoing Reporting in rodent models of ‘chemobrain’: a systematic review assessing compliance with the ARRIVE guidelines Florey Postgraduate Research Conference The University of Adelaide -
2019 - ongoing Methotrexate and Fluorouracil impair learning and memory in the Barnes Maze and 5-Choice Serial Reaction Time Task 28 days post-treatment Florey Undergraduate Research Conference The University of Adelaide -
2018 - ongoing The Effects of The Amyloid Precursor Protein on Neuroinflammation Following Traumatic Brain Injury Florey Undergraduate Research Conference The University of Adelaide -

Connect With Me

External Profiles

Other Links